PRS28 ADD-ON OMALIZUMAB IN PERSISTENT DIFFICULT-TO-TREAT ASTHMA- A 12-MONTH STUDY ON CLINICAL, ECONOMIC OUTCOMES AND RELATED COST/UTILITY
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74490-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)74490-9/fulltext
Title :
PRS28 ADD-ON OMALIZUMAB IN PERSISTENT DIFFICULT-TO-TREAT ASTHMA- A 12-MONTH STUDY ON CLINICAL, ECONOMIC OUTCOMES AND RELATED COST/UTILITY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74490-9&doi=10.1016/S1098-3015(10)74490-9
First page :
Section Title :
Open access? :
No
Section Order :
414